Bumrungrad Hospital Valuation
Is BH-Q undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BH-Q when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BH-Q (THB23.4) is trading above our estimate of fair value (THB16.04)
Significantly Below Fair Value: BH-Q is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BH-Q?
Other financial metrics that can be useful for relative valuation.
What is BH-Q's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿193.96b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7x |
Enterprise Value/EBITDA | 18.4x |
PEG Ratio | 6.6x |
Price to Earnings Ratio vs Peers
How does BH-Q's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 28.3x | ||
BDMS Bangkok Dusit Medical Services | 28.9x | 7.5% | ฿433.1b |
BCH Bangkok Chain Hospital | 32.4x | 16.1% | ฿47.6b |
VIBHA Vibhavadi Medical Center | 29.7x | n/a | ฿29.5b |
RAM Ramkhamhaeng Hospital | 22.3x | 5.2% | ฿36.3b |
BH-Q Bumrungrad Hospital | 26.2x | 4.0% | ฿194.0b |
Price-To-Earnings vs Peers: BH-Q is good value based on its Price-To-Earnings Ratio (26.2x) compared to the peer average (28.3x).
Price to Earnings Ratio vs Industry
How does BH-Q's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: BH-Q is expensive based on its Price-To-Earnings Ratio (26.2x) compared to the TH Healthcare industry average (25.4x).
Price to Earnings Ratio vs Fair Ratio
What is BH-Q's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 26.2x |
Fair PE Ratio | 24.9x |
Price-To-Earnings vs Fair Ratio: BH-Q is expensive based on its Price-To-Earnings Ratio (26.2x) compared to the estimated Fair Price-To-Earnings Ratio (24.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.